Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Warts 1 Vomiting 1 Peripheral Nervous System Diseases 1 Nausea 1 Lung Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

resiquimod 6 VP-102 2 N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 Cantharidin 2 2-Propanol 2 methyl 5-aminolevulinate 1 ammonium trichloro(dioxoethylene-O,O'-)tellurate 1 Sugars 1 Photochemotherapy 1 Nitric Oxide 1 Maltose 1 Interferon-alpha 1 Imiquimod 1 Exercise 1 Equipment and Supplies 1 Cryotherapy 1 3-ingenyl angelate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Warts × Exercise × Clear all

NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed

502 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡